☆ 4.7 Article

In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity

JOURNAL OF NANOBIOTECHNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, Research & Experimental

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death

Yujeong Moon et al.

Summary: In this study, the researchers propose a new strategy to enhance cancer immunotherapy by using anti-PD-L1 peptide-conjugated prodrug nanoparticles (PD-NPs). The PD-NPs are taken up by cancer cells and release the drug, resulting in the disruption of immune-suppressing pathways and the enhancement of T lymphocyte immune responses. The results show that PD-NPs accumulate in tumor tissues and recruit a large amount of immune cells, leading to effective antitumor effects. This strategy has the potential to overcome the toxicity and low response rate issues in current cancer immunotherapy.

THERANOSTICS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery

Man Kyu Shim et al.

Summary: This review outlines the trends and advances in tumor immunotherapy using carrier-free prodrug nanoparticles (PDNPs). PDNPs have shown great potential in reversing immunosuppressive tumor microenvironment and enhancing the response to immune checkpoint blockade therapy. This strategy provides a safe and effective drug delivery method with improved therapeutic outcomes.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy

Man Kyu Shim et al.

Summary: This review discusses recent advances in using nano-sized drug delivery systems (Nano-DDS) to enhance immune checkpoint blockade (ICB) therapy by reversing cold tumors with an immunosuppressive tumor microenvironment (ITM) into immunogenic hot tumors. It classifies the types of immunogenic cell death (ICD) inducers that initiate or enhance anti-tumor immune responses and highlights their extensive combination with immune modulators using Nano-DDS.

EXPERT OPINION ON DRUG DELIVERY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance

Jinseong Kim et al.

Summary: The study presents a potent and safe cancer-specific combination therapy strategy using DOX prodrug nanoparticles and Bcl-2 inhibitor Navitoclax to overcome acquired drug resistance during chemotherapy, showing enhanced therapeutic efficacy in mouse models and reduced systemic toxic side effects in normal organs.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy

Man Kyu Shim et al.

Summary: The study developed a claudin-4-targeting drug carrier that efficiently accumulated in pancreatic cancer tissues, suppressed tumor growth with minimal toxicity to normal tissues. This claudin-4-targeting drug carrier may represent a promising new approach for treating pancreatic cancer.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Engineering, Biomedical

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Suah Yang et al.

Summary: The construction of cancer-activated DOX prodrug nanoparticles provides a promising approach to enhance anticancer immune responses while minimizing side effects and systemic immunosuppression. These nanoparticles selectively target cancer cells, inducing cytotoxicity and immunogenic cell death, leading to increased response to checkpoint inhibitor immunotherapy.

BIOMATERIALS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy

Jiwoong Choi et al.

Summary: Immune checkpoint blockade is a promising approach for cancer immunotherapy, but many patients do not respond due to the immunosuppressive tumor microenvironment. This study proposes visible-light-triggered prodrug nanoparticles (LT-NPs) to reverse the immunosuppressive tumor microenvironment and enhance checkpoint blockade immunotherapy, showing promising results in tumor models.

ACS NANO (2021)

Add to Collection

Review Materials Science, Biomaterials

Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy

Suah Yang et al.

Summary: Nanoparticle-based ICD inducers have potential in effectively inducing antitumor immune responses while avoiding severe toxicity, thus enhancing the therapeutic efficacy of cancer immunotherapy.

JOURNAL OF MATERIALS CHEMISTRY B (2021)

Add to Collection

Article Pharmacology & Pharmacy

Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment

Eun Hyang Jang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity

Ju Hee Ryu et al.

ADVANCED MATERIALS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound

Yongwhan Choi et al.

PHARMACEUTICS (2020)

Add to Collection

Article Engineering, Biomedical

Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy

Man Kyu Shim et al.

BIOMATERIALS (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Cardiomyocyte uptake mechanism of a hydroxyapatite nanoparticle mediated gene delivery system

Hiroaki Komuro et al.

BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

Man Kyu Shim et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Add to Collection

Review Medicine, Research & Experimental

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy

Seungho Lim et al.

THERANOSTICS (2019)

Add to Collection

Article Pharmacology & Pharmacy

Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs

Bom Jung et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles

Ji Young Yhee et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Add to Collection

Article Chemistry, Applied

Heat shock responsive drug delivery system based on mesoporous silica nanoparticles coated with temperature sensitive gatekeeper

In-Hye Cho et al.

MICROPOROUS AND MESOPOROUS MATERIALS (2017)

Add to Collection

Article Engineering, Biomedical

In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface

Sangmin Lee et al.

BIOMATERIALS (2017)

Add to Collection

Review Pharmacology & Pharmacy

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Jennifer I. Hare et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Add to Collection

Article Nanoscience & Nanotechnology

Analysis of nanoparticle delivery to tumours

Stefan Wilhelm et al.

NATURE REVIEWS MATERIALS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death

Hazel England et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Add to Collection

Article Chemistry, Multidisciplinary

Self-assembled glycol chitosan nanoparticles for disease-specific theranostics

Ji Young Yhee et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Add to Collection

Review Pharmacology & Pharmacy

Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy

Ju Hee Ryu et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Add to Collection

Article Chemistry, Multidisciplinary

Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency

Jin Hee Na et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Add to Collection

Review Chemistry, Multidisciplinary

In Vivo Targeted Delivery of Nanoparticles for Theranosis

Heebeom Koo et al.

ACCOUNTS OF CHEMICAL RESEARCH (2011)

Add to Collection

Article Rheumatology

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

Sergei I. Grivennikov et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Add to Collection

Article Biochemistry & Molecular Biology

BNip3 is a mediator of TNF-induced necrotic cell death

Jee-Youn Kim et al.

APOPTOSIS (2011)

Add to Collection

Article Engineering, Biomedical

Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models

Jin Hee Na et al.

BIOMATERIALS (2011)

Add to Collection

Article Chemistry, Multidisciplinary

Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy

So Jin Lee et al.

JOURNAL OF CONTROLLED RELEASE (2011)

Add to Collection

Review Pharmacology & Pharmacy

Imaging and drug delivery using theranostic nanoparticles

Siti M. Janib et al.

ADVANCED DRUG DELIVERY REVIEWS (2010)

Add to Collection

Review Cell Biology

Tumors as Organs: Complex Tissues that Interface with the Entire Organism

Mikala Egeblad et al.

DEVELOPMENTAL CELL (2010)

Add to Collection

Article Chemistry, Multidisciplinary

Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring

Kwangmeyung Kim et al.

JOURNAL OF CONTROLLED RELEASE (2010)

Add to Collection

Article Engineering, Biomedical

Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice

So Jin Lee et al.

BIOMATERIALS (2009)

Add to Collection

Article Chemistry, Multidisciplinary

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles

Hae Yun Nam et al.

JOURNAL OF CONTROLLED RELEASE (2009)

Add to Collection

Article Engineering, Biomedical

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy

Jong-Ho Kim et al.

BIOMATERIALS (2008)

Add to Collection

Article Engineering, Biomedical

In vitro and in vivo degradation behavior of acetylated chitosan porous beads

Sung Mook Lim et al.

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2008)

Add to Collection

Article Chemistry, Multidisciplinary

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles

Ho-Young Hwang et al.

JOURNAL OF CONTROLLED RELEASE (2008)

Add to Collection

Article Chemistry, Multidisciplinary

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy

Kyung Hyun Min et al.

JOURNAL OF CONTROLLED RELEASE (2008)

Add to Collection

Article Chemistry, Multidisciplinary

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice

Jong-Ho Kim et al.

JOURNAL OF CONTROLLED RELEASE (2008)

Add to Collection

Article Chemistry, Multidisciplinary

Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier

S Mitra et al.

JOURNAL OF CONTROLLED RELEASE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.